Biomedical Engineering

Owlstone Medical, a global leader in breath-based diagnostics through its proprietary Breath Biopsy® platform, has announced an equity investment of up to $2.3 million USD (approximately £1.7 million) from the Cystic Fibrosis Foundation. The funding will be used to support the development of a non-invasive breath test for the detection of Pseudomonas aeruginosa (PA) in patients with cystic fibrosis (CF).

Northwestern University engineers have unveiled a groundbreaking wearable device that replicates the nuanced sensations of human touch, promising to revolutionise how we interact with digital and physical environments.

Anterior cruciate ligament (ACL) injuries are among the most common and challenging orthopedic conditions faced by athletes and active individuals worldwide. With over 400,000 ACL reconstruction (ACLR) surgeries performed globally each year, the demand for more reliable and long-lasting treatments has never been higher. Despite ACLR boasting a success rate of over 90 percent, a significant number of patients continue to experience complications such as the need for revision surgery and the onset of long-term osteoarthritis. These issues have spurred a growing interest in alternative graft materials, with artificial ligaments emerging as a promising solution for the future of ACL repair.